関連する実験動画
Updated: Jan 27, 2026
01:26
Coronary Artery Disease IV: Preventive Measures
Published on: June 19, 2025
622
光学空洞の中の単一の原子からなる基本的な量子ネットワーク
Stephan Ritter1, Christian Nölleke, Carolin Hahn
1Max-Planck-Institut für Quantenoptik, Hans-Kopfermann-Strasse 1, 85748 Garching, Germany. stephan.ritter@mpq.mpg.de
Nature
|April 14, 2012
まとめ
研究者らは,原子空洞系を用いたプロトタイプ量子ネットワークを開発した. このネットワークは,安全な量子情報転送とノード間の絡み合いを実現し,スケーラブルな量子コンピューティングと通信の道を開く.
科学分野:
- 量子情報科学とは,量子情報科学である.
- 量子ネットワークは量子ネットワークです.
- 原子物理 原子物理学
背景:
- 量子ネットワークは,分散型量子コンピューティングと通信に不可欠です.
- 既存の量子ネットワークアーキテクチャは,スケーラビリティの課題に直面しています.
- アトム・キャビティ・システムは,量子情報処理のための有望なプラットフォームを提供します.
研究 の 目的:
- 光学空洞の単一の原子に基づく量子ネットワークのプロトタイプを提示する.
- 普遍的な量子ネットワークのノードとしてのこれらの原子空洞システムの機能性を実証する.
- リモートノード間の絡み合いの作成と操作を展示するために.
主な方法:
- 光学腔に埋め込まれた単一の原子をネットワークノードとして利用する.
- 単一の光子の一貫した交換を通じて量子接続性を達成する.
- 状態操作のためのローカル量子ビット (クビット) の回転を実装する.
主要な成果:
- 光子量子情報のための普遍的なノードとしての原子空洞系を実証した.
- ノード間の原子量子状態の忠実な転送を達成しました.
- 異なる研究室で2つの同一のノード間の絡み合いを作り,操作する.
結論:
- 空洞ベースのアプローチは,量子ネットワークの効率的な方法を提供します.
- このスケーラブルなアーキテクチャは,大規模な量子ネットワークへの明確な道筋を提供します.
- 実証された機能は,将来の量子コンピューティングと通信アプリケーションにとって不可欠です.
関連する概念動画
Coronary Artery Disease II: Pathophysiology
409
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
409
Coronary Artery Disease I: Introduction
958
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
958
Coronary Artery Disease IV: Preventive Measures
622
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
622
Preventive Healthcare Services
1.9K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.9K
Factors Affecting the Risk of Infection
13.3K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.3K
Factors Affecting Protein-Drug Binding: Protein-Related Factors
538
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
538